Medicine shortages are escalating as low drug prices push manufacturers out of the market, creating dangerous supply gaps. Without intervention, hospitals will face critical shortages of essential medicines, jeopardizing patient care.
The recent report of paracetamol shortages in English hospitals is just the beginning. Medicine supply chains are intricate and global, with multiple failure points sensitive to geopolitical shocks. Brexit has exacerbated the UK's vulnerability, cutting off access to EU medicine reserves and complicating cross-border logistics.
Why Low Drug Prices Cause Shortages
Our research indicates that shortages are concentrated in off-patent generic and biosimilar markets. While low prices drive health system savings and affordability, pushing prices too low forces manufacturers to exit. This leaves markets with few suppliers, dangerously exposed to disruptions or demand spikes.
When shortages occur, the NHS bears the cost through higher prices, expensive substitutes, and heavy staff burdens from emergency procurement and rationing. Patients suffer most, facing delayed treatment and worse outcomes.
The Delicate Balance of Drug Pricing
Governments must weigh pricing controls against the costly damage of drug shortages. The solution lies in using regulatory, pricing, and approval decisions to encourage competition and nurture supply chain resilience.
| Factor | Low Drug Prices | Balanced Pricing |
|---|---|---|
| Manufacturer Participation | Low, many exit | Healthy, sustained competition |
| Supply Chain Resilience | Weak, prone to shortages | Strong, diversified suppliers |
| NHS Cost Impact | High due to emergency measures | Lower long-term, stable procurement |
| Patient Outcomes | Delayed treatment, worse outcomes | Timely access, better health |
- Low prices drive manufacturers out, reducing competition.
- Fewer suppliers increase vulnerability to disruptions.
- Shortages lead to higher NHS costs and patient harm.
- Balanced pricing ensures supply chain stability and innovation.
FAQ
What causes medicine shortages?
Medicine shortages are primarily caused by unsustainably low prices that force manufacturers to exit the market, leaving too few suppliers. Other factors include geopolitical shocks, Brexit-related logistics issues, and demand spikes.
How do low drug prices affect patients?
Low drug prices can lead to shortages, resulting in delayed treatment, substitution with less effective alternatives, and worse health outcomes for patients.
What can governments do to prevent shortages?
Governments should use regulatory, pricing, and approval decisions to encourage competition and support a diverse supplier base. Balanced pricing that ensures reasonable profits can sustain manufacturer participation and supply chain resilience.
In conclusion, driving drug prices too low is a recipe for medicine shortages. Policymakers must strike a balance to protect both affordability and supply chain integrity.